•  

    SeekIn 思勤

     

    seek and you will find

    真理至上,以人为本

  • About us

    SeekIn Inc is a biotech company founded in early 2018 in Shenzhen, China, focusing on blood-based pan cancer early detection utilizing next-generation sequencing and artificial intelligence. Since founded, SeekIn has been committed to provide cutting-edge and cost-effective solutions for cancer early detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn also developed novel molecular tests for leukemia patients. Its cancer early detection technology has been applied to canines as well. With its proprietary technical advances, SeekIn has launched a number of research and clinical studies in collaboration with top-tier hospitals in China. SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.

  • In October 2020,Dr. Mao was invited to give a talk on TEDxTheBoud's annual meeting again (TEDxTheBund talk in 2018). As TED's vision is the power of ideas to change the world, his wish is to use early detection to control cancer, the emperor of all maladies.

     

    I hope that with all our efforts today, when we identify a positive case, the person will say to me,“Dr. Mao, no worries. I just have cancer”.

     

    —— Mao Mao

    Dr. Mao's TEDxTheBund talk in 2020

  • Our solution

    multiplex, stepwise, cost-effective blood-based cancer screening

    A NGS test to capture cancer genetic features in plasma.

    To calculate cancer risk score.

    Non-invasive blood based screening method,10ml blood.

    所有文章
    ×

    ©2018 SeekIn Cancer. All Rights Reserved.